Anti-Human IL2RA Recombinant Antibody(Daclizumab)
-
产品编号
YR1002
-
别名
科研级Daclizumab, Anti-IL2RA Recombinant Antibody, Research Grade Daclizumab
-
规格
- 1mg
- 5mg
Alias | 科研级Daclizumab, Anti-IL2RA Recombinant Antibody, Research Grade Daclizumab |
Catalog Number | YR1002 |
Molecular Name | Daclizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Daclizumab (trade name Zinbryta) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells. |
CAS Number | 152923-56-3 |
Application | ELISA, Neut, IF, IP, FCM, FuncS, MRI |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 142.61 kDa |
Target | IL2RA[Homo sapiens] |